Any questions? Contact us+49 761-389 49-0
To our Austria Webshop
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer recognition
Customer-specific caching
Individual prices
PayPal payments
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Statistics & Tracking
Affiliate program
Google Tag Manager
Track device being used

Review of Guidelines for Interpreting Somatic Hypermutation Status

Teaser-IVS-01

In this presentation, Prof. Dr. Siby Sebastian will discuss the current guidelines for assessing, interpreting, and reporting somatic hypermutation (SHM) status in chronic lymphocytic leukemia (CLL). The focus will be on laboratory experience with the use of high-throughput/next-generation sequencing methods for the assessment of SHM status.

Tags: CLL, SHM status , chronic lymphocytic leukemia, somatic hypermutation , next-generation sequencing , NGS, IVS, Invivoscribe
26 Jan 2022
Related products
LymphoTrack® Dx IGH FR3 Assay Panel - Illumina MiSeq® – CE-IVD LymphoTrack® Dx IGH FR3 Assay Panel - Illumina...
€4,871.00
LymphoTrack® Dx IGH FR1/2/3 Assay Panel - Illumina MiSeq® – CE-IVD LymphoTrack® Dx IGH FR1/2/3 Assay Panel -...
€13,435.00
LymphoTrack® Dx IGH FR2 Assay Panel - Illumina MiSeq® – CE-IVD LymphoTrack® Dx IGH FR2 Assay Panel - Illumina...
€4,871.00
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the usability of this website, serve for direct advertising or simplify interaction with other websites and social networks, will only be used with your consent.
Decline Accept all Configure